Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 6/20 | 0.88 |
| ▸ | LPL | P06858 | 5/20 | 0.42 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.42 |
| ▸ | MGLL | Q99685 | 1/20 | 0.42 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.40 |
| ▸ | BID | P55957 | 3/20 | 0.40 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.40 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.40 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.40 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | EP300 | Q09472 | 1/20 | 0.40 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.40 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.40 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.40 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.40 |
| ▸ | THRA | P10827 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4449189 | 0.94 | LIPG (1.00) | LIPGLPLTRPV1MGLLBID | |
| SCHEMBL6153283 | 0.94 | LIPG (1.00) | LIPGLPLTRPV1MGLLBID | |
| SCHEMBL29670093 | 0.94 | LIPG (1.00) | LIPGLPLTRPV1MGLLBID | |
| SCHEMBL31403378 | 0.94 | LIPG (1.00) | LIPGLPLTRPV1MGLLBID | |
| SCHEMBL11415024 | 0.94 | LIPG (1.00) | LIPGLPLTRPV1MGLLBID | |
| SCHEMBL31591938 | 0.94 | LIPG (1.00) | LIPGLPLTRPV1MGLLBID | |
| SCHEMBL435360 | 0.94 | LIPG (1.00) | LIPGLPLTRPV1MGLLBID | |
| SCHEMBL29670235 | 0.91 | LIPG (0.96) | LIPGLPLTRPV1MGLLBID | |
| SCHEMBL747937 | 0.91 | LIPG (0.96) | LIPGLPLTRPV1MGLLBID | |
| SCHEMBL30445070 | 0.90 | LIPG (0.73) | LIPGLPLTRPV1MGLLBID |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160178638-A1 | Glucose Sensor Molecule | VANTIVE HEALTH GMBH (CH) | 2016-06-23 | — | — | US | disclosed |
| US-9222941-B2 | Glucose sensor molecules | LIGHTSHIP MEDICAL LIMITED (GB) | 2015-12-29 | — | — | US | disclosed |
| US-20140147934-A1 | Glucose sensor molecules | ARES CAPITAL CORPORATION | 2014-05-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160178638-A1 | Glucose Sensor Molecule | GPR119, GCKR, IRS1 | LIPG 1498/4885LPL 2339/4885TRPV1 2247/4885 |
| US-20140147934-A1 | Glucose sensor molecules | GPR119, GCKR, IRS1 | LIPG 1504/4885LPL 2222/4885TRPV1 2231/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.